We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.63%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$921M
AUM Growth
-$85.5M
Cap. Flow
-$110M
Cap. Flow %
-11.98%
Top 10 Hldgs %
14.09%
Holding
5,143
New
1,384
Increased
1,284
Reduced
1,171
Closed
1,233

Sector Composition

Rank Sector Weight
1 Financials 13.75%
2 Technology 8.29%
3 Industrials 7.33%
4 Healthcare 6.94%
5 Consumer Discretionary 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
676
Lam Research
LRCX
$398B
$179K 0.02%
+16,910
New +$172K
VER
677
DELISTED
VEREIT, Inc.
VER
$179K 0.02%
4,226
+4,106
+3,422% +$182K
CABO icon
678
Cable One
CABO
$254M
$178K 0.02%
286
+270
+1,688% +$160K
PATK icon
679
Patrick Industries
PATK
$2.88B
$178K 0.02%
+5,245
New +$155K
RGA icon
680
Reinsurance Group of America
RGA
$15.5B
$177K 0.02%
1,410
-468
-25% -$54.9K
EWP icon
681
iShares MSCI Spain ETF
EWP
$2.14B
$176K 0.02%
6,652
+6,552
+6,552% +$173K
MAC icon
682
Macerich
MAC
$7.26B
$176K 0.02%
+2,488
New +$178K
SM icon
683
SM Energy
SM
$7.44B
$176K 0.02%
5,080
-3,004
-37% -$109K
ASB icon
684
Associated Banc-Corp
ASB
$5.99B
$175K 0.02%
7,078
+1,394
+25% +$30.7K
MMYT icon
685
MakeMyTrip
MMYT
$5.95B
$175K 0.02%
+7,870
New +$196K
ALXN
686
DELISTED
Alexion Pharmaceuticals
ALXN
$175K 0.02%
+1,429
New +$175K
LPT
687
DELISTED
Liberty Property Trust
LPT
$175K 0.02%
4,418
-1,648
-27% -$64.5K
DVA icon
688
DaVita
DVA
$14.6B
$174K 0.02%
2,720
-268
-9% -$16.7K
LEXEA
689
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$174K 0.02%
+4,390
New +$186K
MUX icon
690
McEwen Inc
MUX
$1.12B
$173K 0.02%
5,926
+2,202
+59% +$68.1K
STZ icon
691
Constellation Brands
STZ
$22.4B
$173K 0.02%
1,129
+432
+62% +$68.6K
ASH icon
692
Ashland
ASH
$3.31B
$172K 0.02%
3,221
-3,322
-51% -$182K
TLRD
693
DELISTED
Tailored Brands, Inc.
TLRD
$172K 0.02%
6,716
+6,616
+6,616% +$128K
SRCL
694
DELISTED
Stericycle Inc
SRCL
$171K 0.02%
2,220
+2,161
+3,663% +$163K
AVP
695
DELISTED
Avon Products, Inc.
AVP
$171K 0.02%
33,858
+26,918
+388% +$156K
STMP
696
DELISTED
Stamps.com, Inc.
STMP
$171K 0.02%
+1,495
New +$155K
UAA icon
697
Under Armour
UAA
$2.92B
$170K 0.02%
5,869
-1,239
-17% -$40.7K
LEA icon
698
Lear
LEA
$6.21B
$169K 0.02%
1,280
+763
+148% +$96K
PB icon
699
Prosperity Bancshares
PB
$8.98B
$169K 0.02%
2,354
+1,224
+108% +$76.5K
OKS
700
DELISTED
Oneok Partners LP
OKS
$169K 0.02%
+3,935
New +$163K

Similar funds

Tower Research Capital (TRC)'s Q4 2016 Portfolio in Review

As of Q4 2016, Tower Research Capital (TRC) held 5,143 positions worth $921M, down 8.5% from $1.01B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) withdrew a net $110M in Q4 2016, closing 1,233 positions and reducing 1,171 holdings. Its most notable exit was Vanguard Real Estate ETF, an estimated $18.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 3.3% a quarter earlier, followed by Technology and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Biotechnology ETF worth $9.93M.

  • Tower Research Capital (TRC)'s largest Q4 2016 buy was iShares Biotechnology ETF: 112,296 shares worth $9.93M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2016, an estimated $11.2M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $265M.
  • Tower Research Capital (TRC) fully exited Vanguard Real Estate ETF in Q4 2016, selling an estimated $18.2M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $921M portfolio in Q4 2016.
  • Tower Research Capital (TRC) opened 1,384 new positions and closed 1,233 in Q4 2016.
  • Tower Research Capital (TRC)'s portfolio value fell 8.5% quarter-over-quarter to $921M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2016, filed 3 Feb 2017.